How we've delivered in 2024-2025

We set ambitions to:

• Fund more research
• Campaign for better healthcare
• Reach more people with information and support
• Improve public understanding of blood cancer.

Read on to see what we've achieved in 2024-2025.

We said we'd increase our research spend to £8 million in 2024-2025. We've exceeded this target, awarding £10.1 million to research, made up of £9.4 million in new grants and £0.7 million in annual funding agreements.

We developed the Blood Cancer Action Plan in partnership with our community. It makes 17 specific recommendations for the government, NHS, and charities to improve the care and treatment people with blood cancer receive.

Following its launch, the plan has provided a key platform for our campaigning work, helping us to build support among politicians and health officials.

In financial year 2024-2025 we gathered data on the short and long-term impacts of our work, helping us understand where we’ve been most effective, and how we can have the greatest impact in future.

In July 2025 we published our Impact Report.

We've awarded over £1.3 million in funding to our first four Early Career Fellows who are working to uncover new understanding about all types of blood cancer.

Through our partnership with the Daphne Jackson Trust, we were also able to support a further fellowship, bringing a talented scientist back to blood cancer research after a career break.

We've funded five major projects with the potential to transform lives – more than we originally planned. Each initiative supports ground-breaking research designed to reach patients within years, not decades, delivering treatments that work better, or cause fewer side effects.

Our successful Direct Referral pilot generated 348 referrals to us, connecting people with essential blood cancer information and support services. We've now expanded our Direct Referral service to 12 NHS Trusts and Health Boards, with additional rollouts planned.

We found significant data gaps, with ethnicity often unrecorded. Knowing that minority ethnic groups are under-represented in clinical trials, we launched a project to understand why. We're now collaborating with Black and South Asian communities to identify and remove barriers to participation.

We increased our income to £21.1 million, including £19.2 million from fundraising activities.

Because of this, we've been able to fund more life-saving research than ever before, reach more people with support and information, and campaign for better care for all those with blood cancer.

Our fundraising income in 2024-2025 came from a variety of sources, including:

• Substantial donations from new and existing partners
• Gifts generously left in Wills
• Fundraising events such as Walk of Light

And thousands of people in the community who donated or raised money for our work.

In 2024-2025 we've increased awareness by two percentage points to 36% compared to last year, and achieved a peak of 40% during the summer. We focused our efforts on reaching and engaging people directly affected by blood cancer who need us most, and our awareness averaged 50% across the year, peaking at 52%.

We'll continue with this important work in the years to come.

> Back to 2024-2025 Annual Report at a glance homepage